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Cell-mediated immunity stems from the prolif-
eration of naive T lymphocytes expressing T cell
antigen receptors (TCRs) specific for foreign
peptides bound to host major histocompatibil-
ity complex (MHC) molecules. Because of the
tremendous diversity of the T cell repertoire, na-
ive T cells specific for any one peptide:MHC
complex (pMHC) are extremely rare. Thus, it is
not known how many naive T cells of any given
pMHC specificity exist in the body or how that
number influences the immune response. By
using soluble pMHC class II (pMHCII) tetramers
and magnetic bead enrichment, we found that
three different pMHCII-specific naive CD4+ T
cell populations vary in frequency from 20 to
200 cells per mouse. Moreover, naive popula-
tion size predicted the size and TCR diversity
of the primary CD4+ T cell response after immu-
nization with relevant peptide. Thus, variation in
naive T cell frequencies can explain why some
peptides are stronger immunogens than others.
INTRODUCTION
Naive T lymphocytes become activated and proliferate
when their antigen receptors (TCRs) bind to cognate pep-
tides presented on major histocompatibility complex
(MHC) molecules (Rudolph et al., 2006; Stockinger et al.,
2006). During infection, antigen-presenting cells display
a multitude of unique foreign peptide:MHC complexes
(pMHC) derived from the invading microbe. The extent
to which naive T cells respond to these various pMHCs
is influenced by howwell antigen-presenting cells process
antigenic peptides (Yewdell, 2006) and induce costimula-
tory ligands and cytokines (Jenkins et al., 2001).It is likely that naive T cell population size also contri-
butes to differences observed in the magnitude of the pri-
mary immune response to different antigenic peptides
(Busch et al., 1998; Homann et al., 2001; McHeyzer-
Williams and Davis, 1995). However, the importance of
this factor is unknown because naive T cells specific for
any one pMHC are very difficult to detect because of their
extremely low frequency, estimated at 100–3000 cells per
mouse (Blattman et al., 2002; Butz and Bevan, 1998;
McHeyzer-Williams and Davis, 1995; Stetson et al.,
2002; Whitmire et al., 2006). Because of this technical lim-
itation, most current knowledge of naive T cell activation is
based on the adoptive transfer of large numbers of mono-
clonal TCR transgenic T cells into histocompatible hosts
(Jenkins et al., 2001). Although such systems have proven
their use, concerns over the effects of intraclonal com-
petition between abnormally large numbers of identical
T cells have reinforced the need to study polyclonal naive
T cells directly (Badovinac et al., 2007; Ford et al., 2007;
Foulds and Shen, 2006; Hataye et al., 2006; Marzo et al.,
2005). Another approach to the study of naive T cell pop-
ulations relies on the use of mice in which one chain of the
TCR is fixed (Malherbe et al., 2004; Zehn and Bevan,
2006). The restricted diversity of the T cell repertoire in
these mice results in larger-than-normal populations of
pMHC-specific cells, thereby facilitating their study. Al-
though the pMHC-specific T cell populations in these
mice are not monoclonal, the increased sizes of these
populations may still pose caveats concerning levels of
competition for ligands.
In this report, we addressed these concerns by devel-
oping a method with pMHCII tetramers and magnetic
beads to study rare CD4+ T cell populations in unmanipu-
lated mice. With this method, we found that naive CD4+
T cell populations specific for different pMHCII vary in
size. Large population size was associated with increased
TCR diversity and a larger primary immune response.
Thus, variation in naive T cell frequency likely explains
why immune responses to some peptides are stronger
than others.Immunity 27, 203–213, August 2007 ª2007 Elsevier Inc. 203
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Enumeration of Naive CD4+ T CellsFigure 1. Primary Immune Responses of
Naive CD4+ T Cells Vary with Respect to
pMHC Specificity
(A) Flow cytometry gates used in all figures to
identify T cells from total spleen and lymph
node cells: side scatter-widthlo (left plot);
CD3+, non-T cell lineage (middle plot); and
either CD4+ or CD8+ (right plot).
(B) Where indicated, B6 mice were injected i.v.
with 50 mg of the indicated peptide plus 5 mg
LPS. Eight days later, spleen and lymph node
cells were harvested and stained with the
indicated tetramer. Representative contour
plots of CD44 versus the indicated tetramers
are shown for non-T cell lineage, CD3+,
CD4+ events gated from 106 total collected
events. The total number of cells for each indi-
vidual mouse shown is indicated below the rel-
evant gate. Mean values ± SD were 2W1S,
115,000 ± 40,000; FliC, 23,000 ± 20,000;
OVA, 7,000 ± 3,000 (n = 4 per group).RESULTS
VariableCD4+TCellResponses toDifferent pMHCs
Three distinct tetramers, each consisting of four identical
biotinylated peptide:I-Ab MHC molecules complexed to
a fluorochrome-labeled streptavidin core, were produced
to study naive polyclonal CD4+ T cell populations. The
peptides used were the 2W1S variant (Rees et al., 1999)
of peptide 52-68 from the I-E alpha chain (Rudensky
et al., 1991), peptide 427-441 from the FliC protein of
Salmonella typhimurium (McSorley et al., 2000), and pep-
tide 323-339 from chicken ovalbumin (Shimonkevitz et al.,
1984). Each of these peptides binds to the I-AbMHCII mol-
ecule expressed in C57BL/6 (B6) mice and is immuno-
genic in this strain.
These pMHCII tetramers were used in conjunction with
flow cytometry in an attempt to detect naive pMHCII-
specific CD4+ T cells. Spleen and lymph node cells were
harvested from naive B6 mice or B6 mice injected intrave-
nously (i.v.) 8 days earlier with the relevant peptides plus
bacterial lipopolysaccharide (LPS) as an adjuvant. Pep-
tides were used for immunization to minimize the effects
of differential antigen processing between epitopes from
different proteins, and an i.v. route of administration was
chosen to provide a synchronous, systemic response. The
cells were then stained with phycoerythrin (PE)-labeled
pMHCII tetramers and antibodies specific for CD3, CD4,
CD8, and a cocktail of non-T cell lineage-specific anti-
bodies to allow for the identification of CD4+ T cells
(CD3+, CD4+, non-T-lineage, CD8 events) (Figure 1A).
Anti-CD44 was also included in the staining cocktail to
identify CD44hi antigen-experienced cells (Dutton et al.,204 Immunity 27, 203–213, August 2007 ª2007 Elsevier Inc.1998). Although the tetramers identified expanded CD44hi
populations of different sizes in the relevant peptide-
injected mice, corresponding CD44lo populations could
not be detected in naive mice (Figure 1B). Thus, this ap-
proach lacked the sensitivity to detect naive pMHCII-
specific T cells and therefore could not be used to deter-
mine whether the differences in the sizes of the expanded
populations were related to naive T cell frequency.
pMHCII Tetramer-Based Enrichment
Detection of pMHCII-specific CD4+ T cells in naive mice
was unfeasible because of the limited capacity of the
flow cytometer to routinely analyze more than about 106
total cells, or only 1/200th of the 2 3 108 nucleated cells
in the lymphoid organs of a mouse, at a given time. Even if
such an analysis was performed with high-speed cell-
sorting technology, the accumulation of low-frequency
background events would become prohibitive to the study
of rare cell populations. The solution to these problems
was to concentrate all the tetramer-binding cells from
a mouse into a smaller sample containing only about 106
total cells, which could then be analyzed in its entirety
with a high signal-to-noise ratio. This was accomplished
by performing a cell-enrichment stepwithmagnetic beads
coupled to antibodies specific for the PE fluorochrome
component of the tetramer (Jang et al., 2003).
To test the efficacy of the tetramer-based enrichment,
known numbers of monoclonal CD4+ T cells from SM1
TCR transgenic mice (McSorley et al., 2002), which ex-
press CD90.1 and a FliC:I-Ab-specific TCR, were mixed
with 2.5 3 108 CD90.2+ spleen and lymph node cells
from a B6 mouse (Figure 2). FliC:I-Ab tetramer staining
Immunity
Enumeration of Naive CD4+ T CellsFigure 2. Tetramer-Based Enrichment Increases the Sensitivity of Detection of Epitope-Specific T Cell Populations
Representative contour plots of CD90.1 versus FliC:I-Ab for CD4+ gated events from mixtures of 2.5 3 108 B6 spleen and lymph node cells and the
indicated numbers of CD90.1+ SM1 TCR transgenic T cells analyzed directly (top) or after tetramer-based enrichment (bottom). SM1 cells are shown
in the upper gate and polyclonal FliC:I-Ab-specific CD4+ T cells in the lower gate. Data are representative of two independent experiments.and flow cytometry was then performed with or without
a preliminary FliC:I-Ab tetramer plus anti-PE magnetic
bead enrichment step. CD90.1+ events were not detected
in samples lacking SM1 cells, demonstrating the absence
of background tetramer staining. Without enrichment,
SM1 cells were not detected until at least 1000 were pres-
ent in themixture. In contrast, as few as 10 SM1 cells were
detected by the enrichment method. Therefore, this tetra-
mer-based enrichment method improved the limit of de-
tection by about 100-fold, to the point where as few as
10 pMHCII-specific cells could be reliably detected in
a background of 2.5 3 108 other cells.
A small population of CD4+ FliC:I-Ab(+) CD90.1 cells of
polyclonal B6 origin was consistently detected in all of the
tetramer-enriched samples (Figure 2). This finding raised
the possibility that this method could detect endogenous
polyclonal pMHCII-specific naive CD4+ T cells. Alterna-
tively, the rare CD4+ T cells that bound the FliC:I-Ab tetra-
mer may have done so nonspecifically. These possibilities
were tested by enriching spleen and lymph nodes cells
from a naive B6 mouse with a mixture of PE-labeled
2W1S:I-Ab and allophycocyanin (APC)-labeled FliC:I-Ab
tetramers followed by anti-PE plus anti-APC magnetic
beads. As shown in Figure 3A, this experiment resulted
in the detection of two mutually exclusive CD4+ popula-
tions: one that bound FliC:I-Ab but not 2W1S:I-Ab, and
a larger one that bound 2W1S:I-Ab but not FliC:I-Ab. The
absence of CD4+ T cells that bound both tetramers
ruled out the possibility that nonspecific binding was res-
ponsible for the enrichment of these distinct populations
of cells.
Several other pieces of evidence indicated that tetra-
mer-binding T cells detected by the enrichment method
were truly pMHCII-specific cells. First, the 2W1S:I-Ab(+)
cells detected in a 2W1S:I-Ab tetramer-enriched sample
from a naive B6mouse had the CD44lo phenotype of naive
T cells (Figure 3B). Second, few if any of these cells ex-pressed CD8 (Figure 3B), which marks pMHCI-specific
T cells. Third, few if any 2W1S:I-Ab(+) T cells were de-
tected in the CD4+ or CD8+ T cells of a 2W1S:I-Ab tetra-
mer-enriched sample of spleen and lymph nodes cells
from an OVA 257-264:Kb-specific TCR transgenic OT-I
mouse (Figure 3C; Hogquist et al., 1994) or an OVA 323-
339:I-Ab TCR transgenic OT-II mouse (Figure 3D; Barnden
et al., 1998). The few CD44lo CD4+ 2W1S:I-Ab(+) cells de-
tected in the OT-II sample likely expressed a 2W1S:I-Ab-
specific TCR produced by rearrangement of an endoge-
nous TCR-Va chain, which can occur in TCR transgenic
mice expressing RAG proteins (Steinmetz et al., 1989).
This contention was supported by the finding that no
CD4+ 2W1S:I-Ab(+) cells were detected among spleen
and lymph node cells from a RAG-deficient OT-II TCR
transgenic mouse or in two other TCR transgenic RAG-
deficient lines containing monoclonal T cells specific for
other pMHCII (Figure 3E). Together, these results indi-
cated that the tetramer-based enrichment method was
sensitive enough to detect rare naive CD4+ T cells specific
for individual pMHCII.
If the cells detected by tetramer-based enrichment
were truly naive pMHCII-specific CD4+ T cells, then they
should show signs of activation when exposed to the rel-
evant peptide. As shown in Figure 4A, about 50% of the
2W1S:I-Ab(+) CD4+ T cells in B6 mice injected i.v. 48 hr
earlier with 2W1S peptide plus LPS expressed CD44
and/or had undergone blastogenesis compared to about
5% of the cells in mice that were injected with LPS alone.
This result could not be explained by preferential expan-
sion of a small number of cells in the peptide-injected
mice because the numbers of 2W1S:I-Ab(+) CD4+ T cells
present in the two groups of mice were similar at this early
time. In addition, 2W1S:I-Ab(+) T cells in a dye-labeled B6
CD4+ T cell population transferred into B6 hosts did not
show appreciable signs of cell division 48 hr after injection
of 2W1S peptide plus LPS (data not shown). These resultsImmunity 27, 203–213, August 2007 ª2007 Elsevier Inc. 205
Immunity
Enumeration of Naive CD4+ T CellsFigure 3. Naive pMHCII-Specific CD4+ T Cells Can Be Detected by Tetramer-Based Enrichment
(A) Representative contour plot of FliC:I-Ab tetramer (APC) versus 2W1S:I-Ab tetramer (PE) for non-T cell lineage CD3+ CD4+ events in the total
spleen and lymph node cell population from a naive B6 mouse after simultaneous enrichment with FliC:I-Ab and 2W1S:I-Ab tetramers.
(B–D) Representative contour plots of CD44 versus 2W1S:I-Ab for CD4+ or CD8+ gated events after 2W1S:I-Ab tetramer enrichment of total spleen and
lymph node cells from a naive B6 (B), an OT-I Rag1+/+ (C), or an OT-II Rag1+/+ TCR transgenic (D) mouse.
(E) Representative contour plots of CD44 versus 2W1S:I-Ab for CD4+ gated events after 2W1S:I-Ab tetramer enrichment of total spleen and lymph
node cells from OT-II Rag1/, SM1 Rag1/, and TEa Rag1/ TCR transgenic mice. Data are representative of at least three independent exper-
iments.showed that peptide-responsive naive CD4+ T cells were
detected by the tetramer-enrichment method.
The efficiency of tetramer-based enrichment was mea-
sured by assaying its capacity to deplete a target popula-
tion from a polyclonal sample. Purified CD4+ T cells
(4 3 107) from naive B6 mice were stained with either
2W1S:I-Ab or FliC:I-Ab tetramer. The stained samples
were then passed over magnetized columns, and the
43 107 cells that did not bind were transferred into lym-
phocyte-deficientRag1/mice, whichwere then injected
intravenously with a mixture of FliC and 2W1S peptides
plus LPS. Eight days later, the number of 2W1S:I-Ab(+)
or FliC:I-Ab(+) cells in the recipient mice was measured206 Immunity 27, 203–213, August 2007 ª2007 Elsevier Inc.by tetramer-based enrichment (Figure 4B). Rag1/ mice
reconstituted with 2W1S:I-Ab-depleted cells contained
a population of CD44hi FliC:I-Ab(+) cells but not 2W1S:
I-Ab(+) cells, whereas Rag1/ mice reconstituted with
FliC:I-Ab-depleted cells contained a large population of
CD44hi 2W1S:I-Ab(+) cells but very few FliC:I-Ab(+) cells af-
ter immunization. These results demonstrated that most, if
not all, of the relevant pMHCII-specific CD4+ T cells in
a naive mouse were captured by the magnetic column.
Naive CD4+ T Cell Population Sizes
The specificity and efficiency of tetramer-based enrich-
ment allowed for the accurate enumeration of naive
Immunity
Enumeration of Naive CD4+ T CellsFigure 4. Tetramer-Binding T Cells Are Responsive to Their Relevant Peptide
(A) 2W1S:I-Ab enrichment was performed on total spleen and lymph node cells from B6 mice injected i.v. 48 hr earlier with 5 mg LPS (left) or 5 mg LPS
plus 250 mg 2W1S peptide (right). CD4+ 2W1S:I-Ab(+) events were then analyzed for CD44 expression and blastogenesis (forward scatter). The total
number of 2W1S:I-Ab(+) cells in each mouse is shown below the relevant gates. Numbers in each quadrant indicate percentages of 2W1S:I-Ab(+)
gated events. Data are representative of at least three independent experiments.
(B) Contour plots of CD44 versus tetramer for 2W1S:I-Ab or FliC:I-Ab enriched spleen and lymph node cells from B6Rag1/ hosts that received either
2W1S:I-Ab or FliC:I-Ab tetramer-depleted cells from naive B6 mice and were then injected i.v. with a mixture of 50 mg 2W1S peptide, 50 mg FliC pep-
tide, and 5 mg LPS 8 days before analysis. The total number of tetramer+ cells for each population is shown below the relevant gate. Data shown are
representative of three independent experiments.CD4+ T cells specific for 2W1S:I-Ab, FliC:I-Ab, or OVA:I-Ab.
Individual naive B6 mice contained on average 190
2W1S:I-Ab-specific, 20 FliC:I-Ab-specific, and 16 OVA:
I-Ab-specific CD4+ T cells in their spleen and lymph nodes
(Figures 5A and 5B). Each of these values was significantly
greater (Student’s t test, two-tailed, p < 0.001) than the
values for CD8+ cells in the same samples or irrelevant
TCR transgenic T cells stained with the same tetramers
(Figure 5B). The 5 CD8+ cells per mouse that were de-
tected with each pMHCII tetramer may have been rare
CD8+ pMHCII-specific T cells similar to those discovered
in Cd4/ mice (Pearce et al., 2004; Tyznik et al., 2004).
The number of 2W1S:I-Ab-specificCD4+ T cellswas signif-
icantly greater than the numbers of FliC:I-Ab- or OVA:I-Ab-
specific T cells (p < 0.001), which were not significantly
different from each other (p = 0.48). Therefore, although
the sizes of individual naive CD4+ T cell populations were
highly consistent among individual mice, these popula-
tions varied in size depending on their pMHCII specificity.
pMHCII-Specific CD4+ T Cell Population Sizes
after Immunization
The naive 2W1S:I-Ab-, FliC:I-Ab-, or OVA:I-Ab-specific
populations were roughly proportional in size to the corre-
sponding expanded populations observed in peptide-
injected mice (Figure 1B). This relationship was explored
inmore detail by the enrichmentmethod over a 3week pe-
riod after i.v. injection with the relevant peptides plus LPS(Figure 5C). The 2W1S:I-Ab-specific population increased
about 300-fold to a peak of 80,000 cells by day 6. The
FliC:I-Ab- and OVA:I-Ab-specific populations also increa-
sed about 300-fold to 5000 and 3000 cells, respectively,
during the same period. Because all three populations ex-
panded at similar rates over the first 6 days after peptide
injection, the larger number of 2W1S:I-Ab-specific cells
present at these times was likely related to the corre-
sponding larger naive population. After day 6, the relation-
ship between pre- and postimmunization frequency was
less clear because the 2W1S:I-Ab-specific population
was contracting whereas the FliC:I-Ab- and OVA:I-Ab-
specific populations continued to increase.
The correspondence between naive population size
and response magnitude was further confirmed in a pep-
tide dose-response experiment. As shown in Figure 5D,
the number of 2W1S:I-Ab-specific T cells was significantly
greater than the number of FliC:I-Ab- and OVA:I-Ab-
specific T cells 4 days after peptide plus LPS injection at
all doses of peptide tested (p < 0.05). Thus, the greater
magnitude of the 2W1S:I-Ab-specific T cell response is
likely due to higher precursor frequency rather than
more efficient peptide presentation.
TCR Variable Segment Diversity
Analysis of TCR variable gene usage as a measure of
clonal diversity provided additional evidence for variation
in naive population sizes. The naive 2W1S:I-Ab-specificImmunity 27, 203–213, August 2007 ª2007 Elsevier Inc. 207
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Enumeration of Naive CD4+ T CellsFigure 5. Naive CD4+ T Cell Populations Vary in Size
(A) Representative contour plots of CD44 versus tetramer for CD4+ events from total spleen and lymph node cells from naive B6mice (top) or B6mice
injected i.v. with 50 mg of the indicated peptide plus 5 mg LPS (bottom) after enrichment with the indicated tetramers.
(B) Total numbers of tetramer+ CD4+ or tetramer+ CD8+ cells after tetramer enrichment of total spleen and lymph node cells from a naive B6mouse, or
tetramer+ CD4+ cells from OT-II Rag1/, TEa Rag1/, or SM1 Rag1/ TCR transgenic mice. Symbols represent individual mice; horizontal bars
indicate mean values.
(C) Mean total number (±SD, n = 2–8) of 2W1S:I-Ab(+) (circles), FliC:I-Ab(+) (triangles), or OVA:I-Ab(+) (diamonds) cells in B6 mice over time after i.v.
injection with 50 mg of the relevant peptide plus 5 mg LPS.
(D) Mean total number (±SD, n = 3) of 2W1S:I-Ab(+) (circles), FliC:I-Ab(+) (triangles), or OVA:I-Ab(+) (diamonds) cells in B6mice 4 days after i.v. injection
with 5 mg LPS plus the indicated amount of relevant peptide.population consistently displayed a V segment usage pat-
tern that was distinct from that of the total CD4+ T cell pop-
ulation (Figures 6A and 6B). Cells expressing Vb4, Vb5, or
Vb11 were over-represented in the 2W1S:I-Ab-specific
population, whereas cells expressing Vb6, Vb8, Vb12,
Vb14, and Va2 were under-represented. This distinct
V segment usage pattern was preserved in the expanded
population of 2W1S:I-Ab-specific cells 4 days after intra-
venous injection with 2W1S peptide plus LPS (Figures
6A and 6B). The similarity between pre- and postimmuni-
zation V segment usage indicated that most of the cells in
the naive 2W1S:I-Ab-specific repertoire proliferated dur-
ing the early stages of the primary immune response.
These results suggested that V segment usageby an ex-
panded T cell population is reflective of the naive starting
population. Therefore, V segment usage in the FliC:I-Ab-
and OVA:I-Ab-specific naive populations, which were too
small to study directly with multiple anti-V segment anti-
bodies, could be estimated from their corresponding ex-208 Immunity 27, 203–213, August 2007 ª2007 Elsevier Inc.panded populations. By pooling tetramer-enriched cells
from mice 8 days after peptide injection, it was possible
to assess usage of all Vb segments for which antibodies
are available. The expanded population of 2W1S:I-Ab-
specific T cells was very diverse (Figure 6C), containing
cells expressing each of the 14 Vb segments tested, but
with over-representation of Vb4, 5, and 11 compared to
the total population of CD4+ T cells. In contrast, the smaller
populations of FliC:I-Ab- and OVA:I-Ab-specific cells were
much less diverse. The FliC:I-Ab-specific population was
dominated by cells expressing Vb8 or Vb12 whereas the
OVA:I-Ab-specific population was comprised primarily of
cells expressing Vb4, Vb5, or Vb8. Because each clone ex-
presses a single Vb segment, the presence of fewer Vb
segments in the smaller populations is consistent with
the possibility that they are comprised of fewer clones
than the larger 2W1S:I-Ab-specific population.
Analysis of cells from individual mice provided addi-
tional evidence for small FliC:I-Ab- and OVA:I-Ab-specific
Immunity
Enumeration of Naive CD4+ T CellsFigure 6. Naive CD4+ T Cell Population Diversity Is Related to Population Size
(A) Total lymph node and spleen cells from naive B6 mice (top) or B6 mice injected i.v. with 50 mg 2W1S peptide plus 5 mg LPS 4 days earlier (bottom)
were stainedwith antibodies to TCR Vb4 and Va2. 2W1S:I-Ab() and 2W1S:I-Ab(+) gated events are represented in histograms by shaded profiles and
solid lines, respectively.
(B) TCR Vb and Va gene segment usage in total CD4+ T cells from naive mice (unfilled bars), or 2W1S:I-Ab(+) CD4+ T cells from naive mice (filled bars)
or mice injected i.v. with 50 mg 2W1S peptide plus 5 mg LPS 4 days earlier (hatched bars). Data are mean values ± SD from 4–8 mice per group.
(C and D) Usage profile for TCR Vb gene segments in total CD4+ T cells from naive B6 mice or tetramer+ CD4+ T cells from B6 mice injected i.v. with
50 mg of the indicated peptide plus 5 mg LPS 8 days earlier. Data are values from pooled samples taken from 4–10mice per group (C) or samples taken
from 4 individual mice per group (D).populations (Figure 6D). Vb usage among these popula-
tions was much more variable than in the case of
2W1S:I-Ab-specific populations. In some individual mice,
the FliC:I-Ab- and OVA:I-Ab-specific populations were
dominated by cells expressing only one of the preferred
Vb segments, whereas in other mice the population con-
tained at least four different Vb segments. Collectively,
the limited diversity of the FliC:I-Ab- andOVA:I-Ab-specific
populations and their greater susceptibility to individual
variation reinforced the finding that their corresponding
naive precursor frequencies are smaller than that of the
2W1S:I-Ab-specific population.
DISCUSSION
Since Klinman’s pioneering studies on the frequency of
naive B cells (Klinman, 1972), numerous efforts have
been made to address this issue with respect to epi-
tope-specific naive T cells. Collectively, past work pro-
duced estimates ranging from 100 to 3000 cells depend-
ing on the epitope in question (Blattman et al., 2002;Butz and Bevan, 1998; McHeyzer-Williams and Davis,
1995; Stetson et al., 2002; Whitmire et al., 2006). Most of
the methods used to arrive at these values relied on indi-
rect means of detection. For example, one approach in-
volved titration of TCR transgenic T cells into normal
mice, which were then exposed to the relevant antigen
(Blattman et al., 2002; Butz and Bevan, 1998; Whitmire
et al., 2006). The number of transferred cells that pro-
duced an antigen-expanded population equal to that pro-
duced from the host was assumed to reflect the number of
host precursors. Moreover, some of these studies in-
volved sampling only a small fraction of the total lymphoid
cells in a mouse, thereby necessitating large extrapolation
factors to calculate total cell numbers. Finally, all of the
early studies produced estimates for only one epitope-
specific population, precluding a definitive comparison
of different population sizes in the same system.
Many of these limitations were overcome in the current
study. Identification of epitope-specific CD4+ T cells was
based directly on pMHCII binding. An enrichment step en-
abled comprehensive sampling of the entire secondaryImmunity 27, 203–213, August 2007 ª2007 Elsevier Inc. 209
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Enumeration of Naive CD4+ T Cellslymphoid compartment of a mouse, thereby obviating the
need for large extrapolation factors in the calculation of
T cell frequency. The use of exclusion gating and relevant
negative controls enabled detection of as few as 5 cells
per mouse. For these reasons, the values obtained here
for naive CD4+ T cell population sizes are likely the most
accurate obtained to date, with the caveat that they may
be slight underestimates resulting from cell loss during
processing and the fact that blood and mucosal-
lymphoid tissues were not sampled.
The values reported here for the number of epitope-
specific CD4+ T cells allows for estimation of the number
of epitopes that could be recognized by the naive reper-
toire. Assuming that each pMHCII-specific CD4+ T cell
population consists of about 100 cells and that there are
about 3 3 107 naive CD4+ T cells in a mouse, it follows
that at least 3 3 105 unique pMHCII specificities exist
within the naive repertoire. However, this is likely a mini-
mum value because individual T cells have been shown
to recognize more than one pMHC (Evavold et al., 1995;
Felix et al., 2007).
Although the naive populations studied in this report
clearly contained multiple clones as evidenced by diverse
Vb usage, the precise number of clones in each is not
clear. Extensive TCR sequence analysis by Casrouge
et al. (2000) showed that individual mice contain about
2 3 106 distinct naive ab TCR clones of 10 cells each in
the spleen. Our findings indicated that the naive popula-
tions of FliC:I-Ab- and OVA:I-Ab-specific T cells numbered
only about 20 per mouse, and that in some individual mice
these populations contained cells expressing one of at
least four different Vb segments. Therefore, because
each T cell expresses only one Vb segment, these popu-
lations must consist of at least four clones each. Indeed,
it is possible that each cell in each populationwas a unique
clone, in which case our results would be more in line with
the recent finding that 50–550 distinct CD8+ T cell clones
recognize each epitope in individual mice (Kedzierska
et al., 2006).
Our results indicate that polyclonal CD4+ T cell popula-
tions expand in proportion to the frequency of their naive
progenitors, at least during the early phase of the primary
immune response. Thus, at least for certain peptides, var-
iations in naive CD4+ T cell population size may account
for the observation that the number of T cells generated
at the peak of the primary immune response to infection
varies for different pMHCII (Busch et al., 1998; Homann
et al., 2001; Masopust et al., 2007).
Notably, not all of the 2W1S:I-Ab tetramer-binding cells
in naive mice showed signs of activation 48 hr after pep-
tide immunization. Our findings that pMHCII tetramer-
binding cells were not detected in CD8+ populations or
in mice containing irrelevant monoclonal T cells provides
strong evidence that tetramer binding was indeed TCR
specific. Thus, the tetramer-binding cells were unlikely
to be background events. On the contrary, the nonrespon-
sive tetramer-binding cells may have simply not encoun-
tered a stimulatory antigen-presenting cell in the 48 hr
time frame. This is supported by our finding that the TCR210 Immunity 27, 203–213, August 2007 ª2007 Elsevier Inc.diversity of the naive 2W1S:I-Ab-specific T cell population
was preserved after 4 days of antigen-induced prolifera-
tion, implying that a high percentage of this naive reper-
toire eventually participated in the response. This conclu-
sion is in agreement with a previous study on another
pMHCII-specific CD4+ T cell population (Malherbe et al.,
2004). Alternatively, the nonresponders may have pos-
sessed TCRs with too low an affinity to become activated
at the peptide dose administered, or the peptidemay have
bound these TCRs as an antagonist (Jameson et al., 1993;
Racioppi et al., 1993; Ruppert et al., 1993). Finally, these
cells may have been recent thymic emigrants that have
been reported to be inherently hyporesponsive to anti-
genic stimulation (Boursalian et al., 2004).
Naive CD8+ T cell populations that vary in size have
been reported to peak at the same time after immunization
(Busch et al., 1998; Homann et al., 2001). In contrast, we
found that a relatively large naive CD4+ T cell population
peaked earlier than two smaller populations, as predicted
by earlier experiments with adoptively transferred TCR
transgenic T cells (Hataye et al., 2006). Because the large
and small populations increased with the same initial ki-
netics, it is possible that the large population became nu-
merous enough to compete for limiting pMHCII, resulting
in an earlier cessation of the response. This is plausible
because unlike CD8+ T cells (Kaech and Ahmed, 2001;
Mercado et al., 2000; van Stipdonk et al., 2001), CD4+
T cells only continue to proliferate in the presence of
pMHC (Obst et al., 2005). Differences in pMHCII persis-
tence at later times after immunization may explain why
the FliC:I-Ab- and OVA:I-Ab-specific populations event-
ually diverged.
Our findings indicate that large naive populations con-
tain more distinct clones than small populations, rather
than more copies of each clone. Large naive populations
may exist for those foreign pMHCII that have properties
(for example, charge and hydrophobicity) that are condu-
cive to recognition by many structurally distinct TCRs. In
contrast, the properties of other foreign pMHCII (for exam-
ple, similarity to self pMHCII) may be conducive to recog-
nition by only a small number of TCRs because of strong
thymic negative selection. Our results agree with other
studies suggesting that such populations can be small
enough that it becomes unlikely that the random process
of TCR gene rearrangement will produce identical sets of
clones in individual mice (Bousso et al., 1998). Immune re-
sponses that depend on very small naive populations may
be inherently variable and at risk for extinction under con-
ditions where total lymphocyte numbers are reduced,
such as aging, chemotherapy, and HIV infection (Prlic
and Jameson, 2002).
EXPERIMENTAL PROCEDURES
Mice
6- to 8-week-old C57BL/6 mice were purchased from the National
Cancer Institute. C57BL/6 Rag1/, SM1 Rag1/ CD90.1+, OT-II
Rag1/, and TEa Rag1/ mice were bred in our facilities. All mice
were housed under specific pathogen-free conditions at the University
of Minnesota, and all experiments were conducted according to
Immunity
Enumeration of Naive CD4+ T Cellsfederal and institutional guidelines under approved Institutional Animal
Care and Use Committee protocols.
Antibodies
Pacific Blue-conjugated anti-B220, CD11b, F4/80 (Caltag), CD11c
(eBioscience); Pacific Orange-conjugated CD8 (eBioscience); FITC-
conjugated CD3, Vb2, Vb3, Vb4, Vb5.1/5.2, Vb6, Vb7, Vb8.1/8.2,
Vb8.3, Vb9, Vb10b, Vb11, Vb12, Vb13, Vb14 (BD PharMingen);
PerCP-conjugated CD4 (BD PharMingen); PE-Cy7-conjugated CD3
(eBioscience); and AlexaFluor 700-conjugated CD44 (eBioscience) an-
tibodies were purchased from the indicated sources.
Plasmid Construction
pRMHa-3 vectors containing the alpha and beta chains of I-Ad under
the control of the metallothionein promoter were provided by
N. Glaichenhaus (Malherbe et al., 2000). These constructs included
C-terminal fusions to acidic and basic leucine zipper domains to force
heterodimerization (Scott et al., 1996), as well as a 63 His epitope tag
on the beta chain construct to facilitate purification and an IgG2a-Fc
domain on the alpha chain to enable multimerization. The I-Ad se-
quences in both constructs were replaced with corresponding I-Ab
alpha and beta sequences generated by PCR amplification. The Fc
domain on the alpha chain was replaced with a BirA biotinylation
signal sequence (Beckett et al., 1999) via splice overlap extension.
Sequences encoding antigenic peptides (2W1S, EAWGALANWAVD
SA; FliC 427-441, VQNRFNSAITNLGNT; OVA 323-339, ISQAVHAAHA
EINEAGR) were fused to the N terminus of the beta chain via a flexible
polyglycine linker (Kozono et al., 1994).
Tetramer Production
Peptide:I-Ab molecules were expressed in Drosophila S2 cells by
means of the Drosophila Expression System kit (Invitrogen). In brief,
cells were cotransfected via calcium phosphate with plasmids encod-
ing the I-Ab alpha chain, the I-Ab beta chain, and a blasticidin resis-
tance gene at a molar ratio of 9:9:1. Transfected cells were selected
in blasticidin-containing media for 2 weeks at 28C, passaged into se-
rum-free media, and scaled up to 1 l cultures in 3 l spinner flasks main-
tained at 150 rpm. When cell densities exceeded 107/ml, expression
was induced by the addition of 0.8 mM copper sulfate. Peptide:I-Ab
heterodimers were purified from supernatants 4–6 days later with
an anti-MHCII (Y3P) affinity column. Bound peptide:I-Ab molecules
were eluted with 0.1 M glycine (pH 2.8), exchanged into 10 mM Tris
(pH 8), and biotinylated with BirA enzyme according to manufacturer’s
instructions (Avidity). Biotinylated peptide:I-Ab molecules were then
separated from free biotin with a Sephacryl S-300 size exclusion col-
umn (GE Healthcare Bio-Sciences). Tetramers were created by mixing
biotinylated peptide:I-Ab molecules with PE- or APC-conjugated
streptavidin (Prozyme) at a molar ratio of 5–8:1 for 1 hr at room temper-
ature and then centrifuging the mixture through a 100 kD molecular
weight cut-off concentration filter (Millipore). The final concentration
of tetramer was then calculated by measuring the absorbance of PE
at 565 nm or APC at 650 nm.
Peptide:MHCII Tetramer-Based Enrichment Protocol
The spleen and inguinal, axillary, brachial, cervical, mesenteric, and
periaortic lymph nodes were harvested for each mouse analyzed. A
single-cell suspension was prepared in 0.2 ml of Fc block (supernatant
from 2.4G2 hybridoma cells grown in serum-free media + 2% mouse
serum, 2% rat serum, 0.1% sodium azide). PE-conjugated tetramer
was added at a concentration of 4–50 nM, depending on the saturating
dose for each production batch, and the cells were incubated at room
temperature for 1 hr, followed by a wash in 15 ml of ice-cold sorter
buffer (PBS + 2% fetal bovine serum, 0.1% sodium azide). In some
cases, PE- and APC-conjugated tetramers were added together at
this step.
The tetramer-stained cells were then resuspended in a volume of
0.4 ml of sorter buffer, mixed with 0.1 ml of anti-PE antibody conju-
gated magnetic microbeads (Miltenyi Biotech) (and in some caseswith anti-APC antibody-conjugated beads, too), and incubated on
ice for 20 min, followed by two washes with 10 ml of sorter buffer.
The cells were then resuspended in 3 ml of sorter buffer and passed
over a magnetized LS column (Miltenyi Biotech). The column was
washed with 3 ml of sorter buffer three time and then removed from
the magnetic field. The bound cells were eluted by pushing 5 ml of
sorter buffer through the column with a plunger.
The resulting enriched fractions were resuspended in 0.1ml of sorter
buffer, and a small volume was removed for cell counting while the rest
of the sample was stained with a cocktail of fluorochrome-labeled an-
tibodies specific for B220, CD11b, CD11c, F4/80, CD3, CD8, CD4, and
CD44. The entire stained sample was then collected on an LSR II flow
cytometer (BD Immunocytometry Systems) and analyzed with FlowJo
software (Treestar). The percentage of tetramer-positive events was
multiplied by the total number of cells in the enriched fraction to calcu-
late the total number of tetramer-positive cells in the mouse.
For TCR-Vb segment analysis, tetramer-enriched fractions from
pooled or individual mouse samples were split into multiple tubes
and stained as described above with the addition of Vb-specific anti-
bodies.
Cell Transfer
CD4+ T cells were purified from several naive B6 mice with a CD4+
T cell isolation kit (Miltenyi Biotech). Half of the purified CD4+ T cells
were stained with 2W1S:I-Ab tetramer and the other half with FliC:
I-Ab tetramer followed by anti-PEmagnetic beads as described above.
Cells (43 107) from each group that did not bind to the magnet were
injected intravenously into Rag1/ mice. Four days later, these mice
were injected intravenously with amixture containing 50 mg 2W1Spep-
tide, 50 mg FliC peptide, and 5 mg LPS (List Biologicals). Eight days
later, individual recipient mice were analyzed for 2W1S:I-Ab- and
FliC:I-Ab-specific CD4+ T cells by tetramer enrichment.
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